- Home
- CELC vs GCBC Comparison
CELC vs GCBC Comparison
Compare CELC & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- GCBC
- Stock Information
- Founded
- CELC 2011
- GCBC 1889
- Country
- CELC United States
- GCBC United States
- Employees
- CELC N/A
- GCBC N/A
- Industry
- CELC Medical Specialities
- GCBC Banks
- Sector
- CELC Health Care
- GCBC Finance
- Exchange
- CELC Nasdaq
- GCBC Nasdaq
- Market Cap
- CELC 489.7M
- GCBC 505.2M
- IPO Year
- CELC 2017
- GCBC 1998
- Fundamental
- Price
- CELC $12.86
- GCBC $31.59
- Analyst Decision
- CELC Strong Buy
- GCBC
- Analyst Count
- CELC 6
- GCBC 0
- Target Price
- CELC $29.17
- GCBC N/A
- AVG Volume (30 Days)
- CELC 232.9K
- GCBC 21.5K
- Earning Date
- CELC 11-14-2024
- GCBC 01-21-2025
- Dividend Yield
- CELC N/A
- GCBC 1.15%
- EPS Growth
- CELC N/A
- GCBC N/A
- EPS
- CELC N/A
- GCBC 1.44
- Revenue
- CELC N/A
- GCBC $64,078,999.00
- Revenue This Year
- CELC N/A
- GCBC N/A
- Revenue Next Year
- CELC N/A
- GCBC N/A
- P/E Ratio
- CELC N/A
- GCBC $21.80
- Revenue Growth
- CELC N/A
- GCBC N/A
- 52 Week Low
- CELC $11.51
- GCBC $24.10
- 52 Week High
- CELC $22.19
- GCBC $37.25
- Technical
- Relative Strength Index (RSI)
- CELC 42.58
- GCBC 56.33
- Support Level
- CELC $11.94
- GCBC $30.95
- Resistance Level
- CELC $13.14
- GCBC $31.83
- Average True Range (ATR)
- CELC 0.51
- GCBC 0.76
- MACD
- CELC 0.07
- GCBC 0.11
- Stochastic Oscillator
- CELC 58.70
- GCBC 100.00
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.